Genopeaks Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 9

Employees

  • Latest Deal Type
  • M&A

Genopeaks Therapeutics General Information

Description

Operator of a liquid biopsy genome analysis company intended to offer precision medicine dedicated to excluding cancer from everyday life. The company provides a liquid biopsy genome analysis service by combining a mutation amplification technique with a next-generation sequencing platform, enabling professionals to detect cancer early and provide customized treatment through liquid biopsy technology.

Contact Information

Website
www.genopeaks.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Room 407, Seongsu A-One Center, 48
  • Ttukseom-ro 17ga-gil, Seongdong-gu
  • Seoul, 26963
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Drug Discovery
Biotechnology
Other Healthcare Technology Systems
Acquirer
Gencurix
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • Room 407, Seongsu A-One Center, 48
  • Ttukseom-ro 17ga-gil, Seongdong-gu
  • Seoul, 26963
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genopeaks Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 26-Jun-2026 Completed Startup
3. Secondary Transaction - Private Completed Startup
2. Seed Round 19-Jan-2022 $2.1M $2.1M Completed Startup
1. Accelerator/Incubator 30-Sep-2021 Completed Startup
To view Genopeaks Therapeutics’s complete valuation and funding history, request access »

Genopeaks Therapeutics Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Genopeaks Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022131803-A1 Ultra-high sensitivity method for selectively amplifying breast cancer genetic mutation, and composition therefor Inactive 15-Dec-2020
WO-2022119423-A1 Ultra-high sensitivity method for selectively amplifying lung cancer gene mutation, and composition therefor Inactive 04-Dec-2020
EP-3536785-A1 Method for preparing dna library derived from ffpe tissue using endonuclease Inactive 04-Nov-2016
EP-3536785-A4 Method for preparing dna library derived from ffpe tissue using endonuclease Inactive 04-Nov-2016
US-11359192-B1 Method for preparing dna library derived from ffpe tissue using endonuclease Inactive 04-Nov-2016 C12N15/1093
To view Genopeaks Therapeutics’s complete patent history, request access »

Genopeaks Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genopeaks Therapeutics Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
HG Initiative Impact Investing Minority
JB Investment (Seoul) Corporate Venture Capital Minority
Tech Incubator Program for Startup Accelerator/Incubator
Union Investment Partners Venture Capital Minority
To view Genopeaks Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Genopeaks Therapeutics FAQs

  • When was Genopeaks Therapeutics founded?

    Genopeaks Therapeutics was founded in 2020.

  • Where is Genopeaks Therapeutics headquartered?

    Genopeaks Therapeutics is headquartered in Seoul, South Korea.

  • What is the size of Genopeaks Therapeutics?

    Genopeaks Therapeutics has 9 total employees.

  • What industry is Genopeaks Therapeutics in?

    Genopeaks Therapeutics’s primary industry is Diagnostic Equipment.

  • Is Genopeaks Therapeutics a private or public company?

    Genopeaks Therapeutics is a Private company.

  • What is Genopeaks Therapeutics’s current revenue?

    The current revenue for Genopeaks Therapeutics is .

  • How much funding has Genopeaks Therapeutics raised over time?

    Genopeaks Therapeutics has raised $2.1M.

  • Who are Genopeaks Therapeutics’s investors?

    HG Initiative, JB Investment (Seoul), Tech Incubator Program for Startup, and Union Investment Partners have invested in Genopeaks Therapeutics.

  • When was Genopeaks Therapeutics acquired?

    Genopeaks Therapeutics was acquired on 26-Jun-2026.

  • Who acquired Genopeaks Therapeutics?

    Genopeaks Therapeutics was acquired by Gencurix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process